Torrent Pharmaceuticals Limited

NSE:TORNTPHARM.NS

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

💻 Telehealth

Location

India

Market Cap

USD 12.62 B

Share Price

USD 37.30

Avg Daily Volume

343,112

Change (1 day)

0.79%

Change (1 year)

10.06%

Change (YTD)

-4.97%

Torrent Pharmaceuticals Limited Net Cash Used For Investing Activities for the year ending March 31, 2025: USD -63.19 M

Torrent Pharmaceuticals Limited Net Cash Used For Investing Activities is USD -63.19 M for the year ending March 31, 2025, a 213.92% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Torrent Pharmaceuticals Limited Net Cash Used For Investing Activities for the year ending March 31, 2024 was USD -20.13 M, a -93.15% change year over year.
Torrent Pharmaceuticals Limited Net Cash Used For Investing Activities for the year ending March 31, 2023 was USD -293.83 M, a 1,034.66% change year over year.
Torrent Pharmaceuticals Limited Net Cash Used For Investing Activities for the year ending March 31, 2022 was USD -25.90 M, a -57.81% change year over year.
Torrent Pharmaceuticals Limited Net Cash Used For Investing Activities for the year ending March 31, 2021 was USD -61.38 M, a 205.16% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Depreciation And Amortization	Dividends Paid

NSE: TORNTPHARM.NS

Torrent Pharmaceuticals Limited

CEO	Mr. Sanjay Gupta
IPO Date	July 1, 2002
Location	India
Headquarters	Torrent House
Employees	15,718
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies 💻 Telehealth

Description

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.